Principal Securities’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-575
Closed -$35.9K 2872
2025
Q3
$35.9K Sell
575
-393
-41% -$27.4K ﹤0.01% 2123
2025
Q2
$77.3K Buy
968
+190
+24% +$15.9K ﹤0.01% 1649
2025
Q1
$60.8K Hold
778
﹤0.01% 1672
2024
Q4
$60.8K Buy
778
+36
+5% +$2.79K ﹤0.01% 1669
2024
Q3
$53.5K Buy
742
+180
+32% +$12.7K ﹤0.01% 1662
2024
Q2
$38.7K Buy
562
+23
+4% +$1.56K ﹤0.01% 1738
2024
Q1
$39.1K Buy
539
+66
+14% +$4.41K ﹤0.01% 1684
2023
Q4
$29K Buy
+473
New +$28.1K ﹤0.01% 1736

Other funds holding PBH

Principal Securities's PBH Position: Q4 2025 in Review

Principal Securities sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 575 shares — an estimated $35.9K sold.

Principal Securities first reported a position in PBH in Q4 2023 and held it in 8 quarters. The position peaked at $77.3K in Q2 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Principal Securities reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 575 Prestige Consumer Healthcare shares in Q4 2025, an estimated $35.9K.
  • Principal Securities first reported a position in Prestige Consumer Healthcare in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Prestige Consumer Healthcare position peaked at $77.3K in Q2 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.